North America holds a notable share of the Albendazole Anthelmintic Drug Market, supported by its advanced healthcare infrastructure, robust pharmaceutical industry, and well-established infectious disease management programs. Although the regional prevalence of parasitic infections is lower than in many developing regions, demand for albendazole remains consistent due to its use in treating...